The anti-viral medication Zanamivir (Relenza), should be administered via a diskhaler device, is not supposed to be suspended and dispensed via nebulizer or mechanical ventilation. The FDA has released a report of a pregnant woman with influenza, who died in relation to the use of zanamivir, which was suspended and administered through a mechanical ventilator, and caused a malfunction in the ventilator equipment (FDA site). The FDA has approved the use of IV peramivir for critically ill patients with influenza.
Categories
Related Posts
by Deepak Asudani, MD, MPH, FHM Whether it is the prompt and expeditious international collaboration to develop an Ebola vaccine, or tardy but promising development of the first anti parasitic malarial vaccine or the fascinating technology utilizing synthetic DNA for vaccine development against MERS, these developments promise to highlight significant strides in vaccine development for […]
Economists describe preferences in two ways: revealed and stated. Say, for example, I asked you to implement a penalty program for your team with the goal of decreasing the number of occasions members did not clean their hands after a patient encounter. Because you know bad hands equal bad outcomes, you’re apt to offer up […]
by Eric Howell, MD, SFHM “Tell me what you know about antibiotics.” That’s the discussion I start with hospitalized patients all the time, right after they ask me to prescribe antibiotics for their simple cough, or other viral-like illness. And, from their perspective, asking for antibiotics makes sense. After all, antibiotics have been the physician’s […]
Leave A Comment